play_arrow

keyboard_arrow_right

skip_previous play_arrow skip_next
00:00 00:00
playlist_play chevron_left
volume_up
chevron_left
  • Home
  • keyboard_arrow_rightArchive forJune, 2024

Month: June 2024

4 Results / Page 1 of 1


Background
play_arrow
share playlist_add
close

Biomanufacturing

Experimenting with AI in Pharma: A Question of Time [Vasyl Chumachenko]

Vasyl Chumachenko June 26, 2024

Vasyl shares his expertise in integrating AI solutions into the pharmaceutical industry and the practical implications of driving innovation and growth. The conversation delves into the use of AI and machine learning models in pharma, including the application of large language models like ChatGPT and GPT-3 for employer education and […]

play_arrow
share playlist_add
close

Featured

Enhancing Compliance and Efficiency in Pharma Manufacturing with AI [Vivek Gera]

Vivek Gera June 19, 2024

Vivek shared his wealth of experience leveraging cutting-edge technologies to enhance compliance and operational efficiency within the pharmaceutical manufacturing industry. Throughout the episode, Vivek delved into the transformative impact of AI on manufacturing, QA, and QC processes, shedding light on how these advancements are revolutionizing productivity and adherence to CGMP […]

play_arrow
share playlist_add
close

Thermal Mapping

Revolutionizing Temperature Control in Pharma [Jakob Konradsen]

Jakob Konradsen June 12, 2024

Jakob Konradsen, the co-founder and head of quality at Eupry emphasized the importance of data integrity and advanced statistical analysis in the pharmaceutical industry. He discussed the challenges related to temperature control and highlighted insights that can benefit GMP professionals. Jakob’s journey from an electrical engineer to an entrepreneur in […]

play_arrow
share playlist_add
close

Featured

How to Navigate GDP Compliance in Pharma [Paul Sarrazin]

Paul Sarrazin June 5, 2024

Paul shares his wealth of experience and insights into innovative strategies and best practices for maintaining quality standards and regulatory compliance in the pharmaceutical supply chain. The discussion delves into the evolving landscape of GDP and the key insights gained from Paul’s recent projects in the industry. The conversation also […]